Technology Solutions

BeiGene to use Medidata’s patient cloud ePRO solution

Tuesday, July 25, 2017

Medidata, a global provider of cloud-based technology and data analytics for clinical research, announced that BeiGene, a clinical-stage biopharmaceutical company developing innovative molecularly targeted and immuno-oncology drugs for the treatment of cancer, will expand its use of the Medidata Clinical Cloud to further digitize patient reporting for its oncology research studies.

[Read More]

Adimab announces platform transfer with Lilly

Friday, July 21, 2017

Adimab, a global leader in the discovery and optimization of fully human monoclonal and bispecific antibodies, has entered into an agreement with Eli Lilly to transfer the Adimab Platform to Lilly for the discovery and optimization of antibody-based drugs in all therapeutic areas. This technology transfer expands an ongoing collaboration between the two companies that was initiated in 2010, which has yielded several undisclosed therapeutic candidates for Lilly.

[Read More]

TrialScope expands languages in trial results portal

Tuesday, July 18, 2017

TrialScope, a global leader in patient-centric clinical trial transparency and compliance solutions, announced that the Trial Results Summaries Portal now supports trial summaries in English and seven additional languages: Chinese, French, German, Japanese, Polish, Russian and Spanish.

[Read More]

EQT VII acquires Certara for $850M

Wednesday, July 12, 2017

The EQT VII fund has agreed to acquire Certara, a provider of technology-driven decision support solutions for drug development, for an enterprise value of $850 million. The company is being acquired from Arsenal Capital Partners. As part of the transaction, Arsenal Capital Partners will retain a minority ownership stake in Certara, with the Company’s current management team, led by Edmundo Muniz, M.D., Ph.D., continuing to lead the organization, building on a multi-year track record of both organic growth and strategic acquisitions.

[Read More]

CRF Health, University Hospital Basel partner for multiple sclerosis clinical trials

Wednesday, July 12, 2017

CRF Health, a global provider of patient-centered eSource technology and service solutions for the life sciences industry, has collaborated with a research group led by Professor Ludwig Kappos at the University Hospital Basel (UHB) to develop an electronic implementation of the Neurostatus-Expanded Disability Status Scale (Neurostatus-EDSS), an established assessment and documentation tool for multiple sclerosis (MS) clinical trials.

[Read More]